CSS
BCYC

Cubist Systematic Strategies’s Bicycle Therapeutics BCYC Stock Holding History

Cubist Systematic Strategies’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$800K Buy
103,410
+15,693
+18% +$118K ﹤0.01% 2050
2025
Q2 		$610K Buy
87,717
+40,468
+86% +$322K ﹤0.01% 2172
2025
Q1 		$401K Sell
47,249
-2,650
-5% -$31.2K ﹤0.01% 2261
2024
Q4 		$699K Sell
49,899
-28,721
-37% -$616K ﹤0.01% 2014
2024
Q3 		$1.78M Sell
78,620
-17,789
-18% -$410K 0.01% 1499
2024
Q2 		$1.95M Buy
96,409
+86,989
+923% +$1.97M 0.01% 1351
2024
Q1 		$235K Sell
9,420
-104,481
-92% -$2.22M ﹤0.01% 3006
2023
Q4 		$2.06M Buy
113,901
+48,356
+74% +$800K 0.01% 1486
2023
Q3 		$1.32M Buy
65,545
+40,848
+165% +$934K 0.01% 1672
2023
Q2 		$630K Sell
24,697
-19,110
-44% -$444K ﹤0.01% 2245
2023
Q1 		$932K Buy
43,807
+30,617
+232% +$768K 0.01% 2241
2022
Q4 		$390K Buy
+13,190
New +$354K ﹤0.01% 3190
2020
Q2 		– Sell
-294
Closed -$4K – 2393
2020
Q1 		$4K Buy
+294
New +$3.75K ﹤0.01% 2099

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Cubist Systematic Strategies's BCYC Position: Q3 2025 in Review

Cubist Systematic Strategies increased its Bicycle Therapeutics (BCYC) stake by 18% in Q3 2025, buying an estimated $118K and bringing the position to 103,410 shares worth $800K. The position accounts for ﹤0.01% of the portfolio, ranked #2050.

Cubist Systematic Strategies first reported a position in BCYC in Q1 2020 and has held it in 13 quarters since. The position peaked at $2.06M in Q4 2023. 99 funds tracked by Wall St. Rank hold BCYC as of Q3 2025.

  • Cubist Systematic Strategies held 103,410 shares of Bicycle Therapeutics worth $800K as of Q3 2025.
  • Cubist Systematic Strategies bought 15,693 Bicycle Therapeutics shares in Q3 2025, an estimated $118K.
  • Bicycle Therapeutics made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2050 holding.
  • Cubist Systematic Strategies first reported a position in Bicycle Therapeutics in Q1 2020 and has held it in 13 quarters since.
  • Cubist Systematic Strategies's Bicycle Therapeutics position peaked at $2.06M in Q4 2023.
  • 99 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.